In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products. On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending […]
medical
USTR EXTENDS CERTAIN CHINA 301 EXCLUSIONS COVERING CERTAIN MEDICAL-CARE PRODUCTS THROUGH SEPTEMBER 30, 2021
In a notice recently posted on its website, the Office of the U.S. Trade Representative (“USTR”) has announced that it is extending 99 expiring China 301 tariff exclusions on medical-care and/or COVID response products. The exclusions on the products in question had been previously extended through March 31, 2021. The USTR has decided to further […]
USTR SOLICITING COMMENTS ON THE REMOVAL OF CHINA SEC. 301 DUTIES FROM ADDITIONAL MEDICAL-CARE PRODUCTS
In a March 23, 2020 notice, the Office of the United States Trade Representative (“USTR”) has solicited comments identifying additional medical-care items that should be excluded from China Section 301 tariffs in light of the ongoing COVID-19 outbreak. The comment period will remain open at least until June 25, 2020 (subject to potential extensions as […]